216 related articles for article (PubMed ID: 21266527)
1. Cyst fluid interleukin-1beta (IL1beta) levels predict the risk of carcinoma in intraductal papillary mucinous neoplasms of the pancreas.
Maker AV; Katabi N; Qin LX; Klimstra DS; Schattner M; Brennan MF; Jarnagin WR; Allen PJ
Clin Cancer Res; 2011 Mar; 17(6):1502-8. PubMed ID: 21266527
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic Fluid Interleukin-1β Complements Prostaglandin E2 and Serum Carbohydrate Antigen 19-9 in Prediction of Intraductal Papillary Mucinous Neoplasm Dysplasia.
Simpson RE; Yip-Schneider MT; Flick KF; Wu H; Colgate CL; Schmidt CM
Pancreas; 2019 Sep; 48(8):1026-1031. PubMed ID: 31404023
[TBL] [Abstract][Full Text] [Related]
3. Prostaglandin E
Yip-Schneider MT; Carr RA; Wu H; Schmidt CM
J Am Coll Surg; 2017 Oct; 225(4):481-487. PubMed ID: 28739154
[TBL] [Abstract][Full Text] [Related]
4. Pancreatic cyst fluid and serum mucin levels predict dysplasia in intraductal papillary mucinous neoplasms of the pancreas.
Maker AV; Katabi N; Gonen M; DeMatteo RP; D'Angelica MI; Fong Y; Jarnagin WR; Brennan MF; Allen PJ
Ann Surg Oncol; 2011 Jan; 18(1):199-206. PubMed ID: 20717734
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic cyst fluid concentration of high-mobility group A2 protein acts as a differential biomarker of dysplasia in intraductal papillary mucinous neoplasm.
DiMaio CJ; Weis-Garcia F; Bagiella E; Tang LH; Allen PJ
Gastrointest Endosc; 2016 Jun; 83(6):1205-9. PubMed ID: 26408423
[TBL] [Abstract][Full Text] [Related]
6. Cyst Fluid Biosignature to Predict Intraductal Papillary Mucinous Neoplasms of the Pancreas with High Malignant Potential.
Maker AV; Hu V; Kadkol SS; Hong L; Brugge W; Winter J; Yeo CJ; Hackert T; Büchler M; Lawlor RT; Salvia R; Scarpa A; Bassi C; Green S
J Am Coll Surg; 2019 May; 228(5):721-729. PubMed ID: 30794864
[TBL] [Abstract][Full Text] [Related]
7. Multiinstitutional Validation Study of Cyst Fluid Protein Biomarkers in Patients With Cystic Lesions of the Pancreas.
McIntyre CA; Rodrigues C; Santharaman AV; Goldman DA; Javed AA; Ciprani D; Pang N; Lokshin A; Gonen M; Al Efishat MA; He J; Burkhart R; Burns W; Weiss M; D'Angelica MI; Kingham TP; Balachandran VP; Drebin JA; Jarnagin WR; Lillemoe KD; Brugge W; Casey B; Lennon AM; Schattner M; Wolfgang CL; Del Castillo CF; Allen PJ
Ann Surg; 2022 Aug; 276(2):e129-e132. PubMed ID: 34793354
[TBL] [Abstract][Full Text] [Related]
8. Multi-institutional Validation Study of Pancreatic Cyst Fluid Protein Analysis for Prediction of High-risk Intraductal Papillary Mucinous Neoplasms of the Pancreas.
Al Efishat MA; Attiyeh MA; Eaton AA; Gönen M; Prosser D; Lokshin AE; Castillo CF; Lillemoe KD; Ferrone CR; Pergolini I; Mino-Kenudson M; Rezaee N; Dal Molin M; Weiss MJ; Cameron JL; Hruban RH; D'Angelica MI; Kingham TP; DeMatteo RP; Jarnagin WR; Wolfgang CL; Allen PJ
Ann Surg; 2018 Aug; 268(2):340-347. PubMed ID: 28700444
[TBL] [Abstract][Full Text] [Related]
9. Cyst fluid carcinoembryonic antigen level is not predictive of invasive cancer in patients with intraductal papillary mucinous neoplasm of the pancreas.
Kucera S; Centeno BA; Springett G; Malafa MP; Chen YA; Weber J; Klapman J
JOP; 2012 Jul; 13(4):409-13. PubMed ID: 22797397
[TBL] [Abstract][Full Text] [Related]
10. Pancreatic cyst fluid protein expression profiling for discriminating between serous cystadenoma and intraductal papillary mucinous neoplasm.
Allen PJ; Qin LX; Tang L; Klimstra D; Brennan MF; Lokshin A
Ann Surg; 2009 Nov; 250(5):754-60. PubMed ID: 19806054
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathologic study of the MIB-1 labeling index (Ki67) and postoperative prognosis for intraductal papillary mucinous neoplasms and ordinary ductal adenocarcinoma.
Takeshita A; Kimura W; Hirai I; Takasu N; Moriya T; Tezuka K; Watanabe T
Pancreas; 2012 Jan; 41(1):114-20. PubMed ID: 22143341
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor II messenger RNA-binding protein-3 is a valuable diagnostic and prognostic marker of intraductal papillary mucinous neoplasm.
Morimatsu K; Aishima S; Yamamoto H; Hayashi A; Nakata K; Oda Y; Shindo K; Fujino M; Tanaka M; Oda Y
Hum Pathol; 2013 Sep; 44(9):1714-21. PubMed ID: 23597774
[TBL] [Abstract][Full Text] [Related]
13. Development and Validation of a Multi-institutional Preoperative Nomogram for Predicting Grade of Dysplasia in Intraductal Papillary Mucinous Neoplasms (IPMNs) of the Pancreas: A Report from The Pancreatic Surgery Consortium.
Attiyeh MA; Fernández-Del Castillo C; Al Efishat M; Eaton AA; Gönen M; Batts R; Pergolini I; Rezaee N; Lillemoe KD; Ferrone CR; Mino-Kenudson M; Weiss MJ; Cameron JL; Hruban RH; D'Angelica MI; DeMatteo RP; Kingham TP; Jarnagin WR; Wolfgang CL; Allen PJ
Ann Surg; 2018 Jan; 267(1):157-163. PubMed ID: 28079542
[TBL] [Abstract][Full Text] [Related]
14. A Gastric Glycoform of MUC5AC Is a Biomarker of Mucinous Cysts of the Pancreas.
Sinha J; Cao Z; Dai J; Tang H; Partyka K; Hostetter G; Simeone DM; Feng Z; Allen PJ; Brand RE; Haab BB
PLoS One; 2016; 11(12):e0167070. PubMed ID: 27992432
[TBL] [Abstract][Full Text] [Related]
15. Cyst Fluid Analysis in Pancreatic Intraductal Papillary Mucinous Neoplasms.
Allen PJ; Iacobuzio-Donahue CA; Klimstra DS
Clin Cancer Res; 2016 Oct; 22(20):4966-4967. PubMed ID: 27573170
[TBL] [Abstract][Full Text] [Related]
16. Value of adding GNAS testing to pancreatic cyst fluid KRAS and carcinoembryonic antigen analysis for the diagnosis of intraductal papillary mucinous neoplasms.
Kadayifci A; Atar M; Wang JL; Forcione DG; Casey BW; Pitman MB; Brugge WR
Dig Endosc; 2017 Jan; 29(1):111-117. PubMed ID: 27514845
[TBL] [Abstract][Full Text] [Related]
17. Pancreatic cyst fluid interleukin-1 beta (IL-1β) level in predicting the risk of malignancy in pancreatic cysts.
Abdellah TA; Shalaby SM; Salem AA; Yousef TM; Saleh SA; Saleh HH; Zaghloul MS; El-Nady MA
Egypt J Immunol; 2022 Oct; 29(4):75-83. PubMed ID: 36198105
[TBL] [Abstract][Full Text] [Related]
18. A large multicenter study of recurrence after surgical resection of branch-duct intraductal papillary mucinous neoplasm of the pancreas.
Yan L; Siddiqui AA; Laique SN; Saumoy M; Kahaleh M; Yoo J; Kalra A; Mathew A; Sterling J; Rao R; Lieberman M; Cosgrove N; Sharaiha RZ
Minerva Gastroenterol Dietol; 2017 Mar; 63(1):50-54. PubMed ID: 27824244
[TBL] [Abstract][Full Text] [Related]
19. [Diagnostic efficacy for predicting intraductal papillary mucinous neoplasms of the pancreas with high grade dysplasia or invasive carcinoma based on the surgery indications in different guidelines].
Li B; Guo SW; Shi XH; Shen S; Zhang GX; Gao SZ; Pan YQ; Xu XF; Jin G
Zhonghua Wai Ke Za Zhi; 2021 May; 59(5):359-365. PubMed ID: 33915626
[No Abstract] [Full Text] [Related]
20. Vascular endothelial growth factor, a novel and highly accurate pancreatic fluid biomarker for serous pancreatic cysts.
Yip-Schneider MT; Wu H; Dumas RP; Hancock BA; Agaram N; Radovich M; Schmidt CM
J Am Coll Surg; 2014 Apr; 218(4):608-17. PubMed ID: 24491241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
